Bone mass in axial spondyloarthritis: A literature review

被引:13
作者
Kilic, Erkan [1 ]
Ozgocmen, Salih [1 ]
机构
[1] Erciyes Univ, Sch Med, Gevher Nesibe Hosp, Div Rheumatol,Dept Phys Med & Rehabil, Talas Yolu Uzeri, TR-38039 Kayseri, Turkey
关键词
Bone mineral density; Dual X-ray absorptiometry; Osteoporosis; Spondyloarthritis; Ankylosing spondylitis;
D O I
10.5312/wjo.v6.i2.298
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
AIM: To review the published literature reporting bone loss in patients with axial spondyloarthritis (SpA) particularly those studies using dual X-ray absorptiometry (DXA) methods. METHODS: This literature review examines the reported bone mass in patients with ax-SpA, particularly those using the DXA methods. The MEDLINE, Web of Science and Scopus databases were searched for relevant articles published between September 1992 and November 2013. Some of used search terms were ankylosing spondylitis (AS), SpA, spondyloarthropathy, bone loss, bone mass, osteopenia, bone mineral density, osteoporosis (OP), densitometry. Studies in which bone loss was investigated by using DXA in patients with SpA were eligible. Each article was reviewed and the key elements were noted. RESULTS: There were 286 hits on MEDLINE, 200 on Web of Science and 476 on Scopus. After applying inclusion and exclusion criteria, we identified 55 articles in our systematic search. The sample size of the studies varied from 14 to 332 patients with SpA. The reported age range varied from 25 to 56 years in the reviewed studies. The symptom duration of patients with axSpA varied from 1.6 to 49 years. There were more males than females in these studies. Most of the recruited females were premenopausal women. Reported HLA-B27 positivity changed between 19% to 95%. The prevalence of OP and osteopenia in patients with SpA varied from 3%-47% to 5%-88%, respectively, in the included studies. In particular, the prevalence of OP and osteopenia ranged from 2.0%-47.0% and 5.0%-78.3%, respectively, in patients with AS. There are conflicting results regarding the relationship among disease activity, acute phase response and bone mass. Some studies suggest good correlation of bone mass with disease activity and acute phase reactants. CONCLUSION: Bone loss may be determined in patients with axSpA at the lumbar spine or proximal femur even in the early phase of the disease and may be associated with inflammation (bone marrow edema) at the vertebral colon.
引用
收藏
页码:298 / 310
页数:13
相关论文
共 63 条
[1]
Biochemical markers of bone remodeling and bone sialoprotein in ankylosing spondylitis [J].
Acebes, C ;
de la Piedra, C ;
Traba, ML ;
Seibel, MJ ;
Martín, CG ;
Armas, J ;
Herrero-Beaumont, G .
CLINICA CHIMICA ACTA, 1999, 289 (1-2) :99-110
[2]
Evidence for inflammation-induced bone loss in non-radiographic axial spondyloarthritis [J].
Akgol, Gurkan ;
Kamanli, Ayhan ;
Ozgocmen, Salih .
RHEUMATOLOGY, 2014, 53 (03) :497-501
[3]
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α [J].
Allali, F ;
Breban, M ;
Porcher, R ;
Maillefert, JF ;
Dougados, M ;
Roux, C .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) :347-349
[4]
Altindag O, 2008, ROMATIZMA, V23, P42
[5]
The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis [J].
Arends, S. ;
Spoorenberg, A. ;
Bruyn, G. A. W. ;
Houtman, P. M. ;
Leijsma, M. K. ;
Kallenberg, C. G. M. ;
Brouwer, E. ;
van der Veer, E. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (05) :1431-1439
[6]
The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study [J].
Arends, Suzanne ;
Spoorenberg, Anneke ;
Houtman, Pieternella M. ;
Leijsma, Martha K. ;
Bos, Reinhard ;
Kallenberg, Cees G. M. ;
Groen, Henk ;
Brouwer, Elisabeth ;
van der Veer, Eveline .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (02)
[7]
Osteopenia in men with mild and severe ankylosing spondylitis [J].
Baek, HJ ;
Kang, SW ;
Lee, YJ ;
Shin, KC ;
Lee, EB ;
Yoo, CD ;
Song, YW .
RHEUMATOLOGY INTERNATIONAL, 2005, 26 (01) :30-34
[8]
The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis [J].
Baskan, Bedriye Mermerci ;
Dogan, Yasemin Pekin ;
Sivas, Filiz ;
Bodur, Hatice ;
Oezoran, Kuersat .
RHEUMATOLOGY INTERNATIONAL, 2010, 30 (03) :375-381
[9]
Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients:: Relationship to disease activity [J].
Borman, P ;
Bodur, H ;
Bingöl, N ;
Bingöl, S ;
Bostan, EE .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2001, 7 (05) :315-321
[10]
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment [J].
Briot, K ;
Garnero, P ;
Le Henanff, A ;
Dougados, M ;
Roux, C .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1137-1140